Studies on humans are limited to the one study on urinary clusterin in diabetes mellitus patients and the encouraging outcomes of the testing multi-biomarker kit containing urinary clusterin in the range of indicators of acute and chronic renal damage. Here, CLU is linked to diabetes mellitus.